Harnessing AI for Healthcare: A New Dawn for South Africa

By Sumona Bose

February 7, 2024

The Need for AI-Driven Healthcare Policy in South Africa

South Africa’s healthcare sector is on the brink of a transformative era, with artificial intelligence (AI) at its helm. However, the current policy frameworks are ill-equipped to foster innovation in this burgeoning field. Five key issues demand immediate attention: outdated legislation, data and algorithmic bias, workforce impact, liability dilemmas, and a dearth of AI system innovation. The establishment of a comprehensive national policy framework addressing these concerns is crucial for the safe, responsible, and regulated adoption of AI in healthcare.

The Innovation Gap: AI Patenting in South Africa

A closer look at the patenting activity within AI in South Africa reveals a stark reality. Despite the country being listed in over 9,000 AI patent applications between 2012 and 2021, only ten patents were filed from within South Africa. This disparity underscores the need for an enabling environment that promotes the development of complex cognitive and creative AI systems.

Public Sector Data: The Key to AI-Driven Healthcare

One of the significant hurdles to AI development in Africa is data availability and the costs associated with its acquisition. The National Digital Health Strategy for South Africa 2019 – 2024 identifies the development of a patient electronic health record as a key priority. This record system could provide a wealth of high-quality data to train AI systems, alleviating the significant investment and effort required to curate non-optimised data.

The concept of using public sector data to develop, train, and improve AI-enabled systems is not new. The Declaration of Cooperation on Artificial Intelligence, ratified by 25 European countries in 2018, saw member states agree to ensure better access to public sector data to fuel AI development.

However, access to sensitive health data raises privacy and security concerns. A robust legal framework or governance system is needed to encourage innovation while preserving patient privacy and security. A federated data system, where data do not leave the participating organisation but can be accessed by authorised individuals to train algorithms, could be the solution.

Conclusion

The establishment of a public sector data institution, alongside the proposed patient electronic record, could incentivise the development and deployment of AI for use in healthcare in South Africa. By providing developers with secure and safe access to health data, we can respect the rights to intellectual property and digital authenticity.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.